Latest filing published 09 Mar 2018 for Interpace Biosciences, INC..
Insider track record
No signal scores available.
Stephen J. Sullivan: trading record in brief
Stephen J. Sullivan has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Interpace Biosciences, Inc. and Covance Inc. In total, 17 filings cover trades dated from 3 February 2006 to 7 March 2018.
No open-market purchase appears, only 1 sale worth €3.5M. Outside the open market, there are 11 share grants and 5 option exercises.
The newest entry dates from 9 March 2018: a share grant, in Interpace Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephen J. Sullivan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,800 sharesCommon StockSEC:0001493152-18-003195:0
- 100,000 sharesCommon StockSEC:0001140361-16-050405:0
- 34,091 shares@ US$1.32Common StockSEC:0001140361-15-023269:0
- 6,522 shares@ US$6.90Common StockSEC:0001140361-11-030927:0
- 5,000 shares@ US$29.69Common StockSEC:0001229881-06-000001:0
- 16,000 shares@ US$10.88Common StockSEC:0001229881-06-000001:1
- 18,000 shares@ US$23.94Common StockSEC:0001229881-06-000001:2
- 13,267 shares@ US$22.95Common StockSEC:0001229881-06-000001:3
- 21,000 shares@ US$17.43Common StockSEC:0001229881-06-000001:4
- 73,267 shares@ US$56.97Common StockSEC:0001229881-06-000001:5
10 of 10 declarations
